Open AccessLevetiracetam Treatment-Associated Acute Rhabdomyolysis in an Adolescent
Author(s) -
Nagehan Aslan,
Dinçer Yıldızdaş,
Behruz Huseyınlı,
Özden Özgür Horoz,
Gülen Gül Mert,
Faruk Ekinci,
Duygu G Ozcanyuz
Publication year - 2020
Publication title -
journal of pediatric intensive care
Language(s) - English
Resource type - Journals
eISSN - 2146-4618
pISSN - 2146-4626
DOI - 10.1055/s-0039-1700951
Subject(s) - rhabdomyolysis , medicine , levetiracetam , etiology , antiepileptic drug , colchicine , intensive care medicine , pediatrics , epilepsy , anesthesia , psychiatry
Etiology of rhabdomyolysis includes hereditary muscle enzyme deficiencies, trauma, viral infections, excessive exercise, hypothyroidism, and medications such as colchicine, lithium, and statins. Several studies have reported that various antiepileptic drugs may induce rhabdomyolysis. Levetiracetam is one of the antiepileptic drugs implicated in the etiology of rhabdomyolysis. Herein, we present a case of rhabdomyolysis in an adolescent treated with levetiracetam. We wanted to draw attention to the increasing trend of levetiracetam-associated rhabdomyolysis frequency in pediatric patients.